| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89234-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89235-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89259-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90617-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06616-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90405-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89744-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-11988-0.2mg | |||
| BSA Free | NBP3-11988-0.1mg | |||
![Flow (Cell Surface): RP105/CD180 Antibody (G28-8) - Low Endotoxin [NBP2-62228] - Surface staining of human peripheral blood cells with anti-CD180 (G28-8) APC.](http://images.novusbio.com/fullsize/RP105-CD180-Antibody-G28-8-Low-Endotoxin-Flow-Cell-Surface-NBP2-62228-img0002.jpg "Flow (Cell Surface): RP105/CD180 Antibody (G28-8) - Low Endotoxin [NBP2-62228] - Surface staining of human peripheral blood cells with anti-CD180 (G28-8) APC.")
![Flow (Cell Surface): RP105/CD180 Antibody (G28-8) - Low Endotoxin [NBP2-62228] - Surface staining of human peripheral blood cells with anti-CD180 (G28-8) PE.](http://images.novusbio.com/fullsize/RP105-CD180-Antibody-G28-8-Low-Endotoxin-Flow-Cell-Surface-NBP2-62228-img0001.jpg)
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0004.jpg "Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.")
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Staining pattern of human peripheral blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0003.jpg)
![Western Blot: CCR1 Antibody (002) [NBP2-89234] - Lane A: HEK293 Whole Cell Lysate Lane B: 293T Whole Cell LysateLysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:43 kDa Observed band size:49 kDa](http://images.novusbio.com/fullsize/CCR1-Antibody-002-Western-Blot-NBP2-89234-img0001.jpg "Western Blot: CCR1 Antibody (002) [NBP2-89234] - Lane A: HEK293 Whole Cell Lysate Lane B: 293T Whole Cell LysateLysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size:43 kDa Observed band size:49 kDa")
![Immunoprecipitation: CCR1 Antibody (002) [NBP2-89234] - Lane A:0.5 mg Hela Whole Cell Lysate Lane B:0.5 mg 293T Whole Cell Lysate2 uL anti-CCR1/CD191 rabbit monoclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-CCR1/CD191 rabbit monoclonal antibody,at 1:100 dilution Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution Developed using the odssey technique. Performed under reducing conditions. Predicted band size: 43 kDa Observed band size: 43 kDa](http://images.novusbio.com/fullsize/CCR1-Antibody-002-Immunoprecipitation-NBP2-89234-img0002.jpg)
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0002.jpg "Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).")
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human spleen with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0001.jpg)
![Immunohistochemistry-Paraffin: CD14 Antibody (001) [NBP2-89259] - Staining of human CD14 in human spleen with rabbit monoclonal antibody (1:200).](http://images.novusbio.com/fullsize/CD14-Antibody-001-Immunohistochemistry-Paraffin-NBP2-89259-img0002.jpg "Immunohistochemistry-Paraffin: CD14 Antibody (001) [NBP2-89259] - Staining of human CD14 in human spleen with rabbit monoclonal antibody (1:200).")
![Immunohistochemistry-Paraffin: CD14 Antibody (001) [NBP2-89259] - Staining of human CD14 in human tonsil with rabbit monoclonal antibody (1:200).](http://images.novusbio.com/fullsize/CD14-Antibody-001-Immunohistochemistry-Paraffin-NBP2-89259-img0001.jpg)
![Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - WB Suggested Anti-UBE2V1 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Brain](http://images.novusbio.com/fullsize/Uev1a-UBE2V1-Antibody-Western-Blot-NBP2-88550-img0001.jpg "Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - WB Suggested Anti-UBE2V1 Antibody. Titration: 1.0 ug/ml. Positive Control: Fetal Brain")
![Western Blot: Uev1a/UBE2V1 Antibody [NBP2-88550] - Host: Rabbit. Target Name: UBE2V1. Sample Tissue: Human Jurkat Whole Cell. Antibody Dilution: 1ug/ml](http://images.novusbio.com/fullsize/Uev1a-UBE2V1-Antibody-Western-Blot-NBP2-88550-img0002.jpg)
![Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (002) [NBP2-90617] - Flow cytometric analysis of Mouse CD229/SLAMF3/Lymphocyte Antigen 9 expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse CD229/SLAMF3/Lymphocyte Antigen 9, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/CD229-SLAMF3-Lymphocyte-Antigen-9-Antibody-002-Flow-Cytometry-NBP2-90617-img0001.jpg "Flow Cytometry: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (002) [NBP2-90617] - Flow cytometric analysis of Mouse CD229/SLAMF3/Lymphocyte Antigen 9 expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse CD229/SLAMF3/Lymphocyte Antigen 9, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: CD229/SLAMF3/Lymphocyte Antigen 9 Antibody (002) [NBP2-90617] - Immunofluorescence staining of mouse CD229/SLAMF3/Lymphocyte Antigen 9 in mouse splenocytes. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90617 antibody (1:60) at 37C 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG Secondary antibody (green).](http://images.novusbio.com/fullsize/nbp2-90617_rabbit-monoclonal-cd229-slamf3-lymphocyte-antigen-9-antibody-002-235202521451722.png)
![Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/ITCH-AIP4-Antibody-01-Flow-Cytometry-NBP3-06616-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: ITCH/AIP4 Antibody (01) [NBP3-06616] - Staining of Human ITCH in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP3-06616 antibody (1:60) at 37? 1 hour. Then cells were stained with the Alexa Fluor 488-conjugated Goat Anti-mouse IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp3-06616_mouse-monoclonal-itch-aip4-antibody-01-23520251433151.png)
![Flow Cytometry: Fc gamma RI/CD64 Antibody (027) [NBP2-90405] - Flow cytometric analysis of Mouse Fc gamma RI/CD64 expression on Raw264.7 cells. Cells were stained with purified anti-Mouse Fc gamma RI/CD64, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-027-Flow-Cytometry-NBP2-90405-img0001.jpg "Flow Cytometry: Fc gamma RI/CD64 Antibody (027) [NBP2-90405] - Flow cytometric analysis of Mouse Fc gamma RI/CD64 expression on Raw264.7 cells. Cells were stained with purified anti-Mouse Fc gamma RI/CD64, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (027) [NBP2-90405] - Immunofluorescence staining of mouse Fc gamma RI/CD64 in Raw264.7 cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90405 antibody (1:60) at 37C 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG Secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cells membrane.](http://images.novusbio.com/fullsize/nbp2-90405_rabbit-monoclonal-fc-gamma-ri-cd64-antibody-027-23520252135127.png)
![Flow Cytometry: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Analysis of Human TFRC(CD71) expression on U937 cells. Cells were stained with purified anti-Human TFRC(CD71), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/TfR-Transferrin-R-Antibody-040-Flow-Cytometry-NBP2-89744-img0002.jpg "Flow Cytometry: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Analysis of Human TFRC(CD71) expression on U937 cells. Cells were stained with purified anti-Human TFRC(CD71), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: TfR (Transferrin R) Antibody (040) [NBP2-89744] - Staining of Human TFRC in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP2-89744 antibody (1:60) at 37c 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated goat Anti-rabbit IgG secondary antibody (green). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp2-89744_rabbit-monoclonal-tfr-transferrin-r-antibody-040-235202514492378.png)
![Western Blot: Insulin Antibody [NBP1-45662] - Analysis using recombinant human Insulin.](http://images.novusbio.com/fullsize/Insulin-Antibody-Western-Blot-NBP1-45662-img0002.jpg "Western Blot: Insulin Antibody [NBP1-45662] - Analysis using recombinant human Insulin.")